Literature DB >> 11773401

Proteolytic processing of human cytomegalovirus glycoprotein B is dispensable for viral growth in culture.

Tanja Strive1, Eva Borst, Martin Messerle, Klaus Radsak.   

Abstract

Glycoprotein B (gB) of human cytomegalovirus (HCMV), which is considered essential for the viral life cycle, is proteolytically processed during maturation. Since gB homologues of several other herpesviruses remain uncleaved, the relevance of this property of HCMV gB for viral infectivity is unclear. Here we report on the construction of a viral mutant in which the recognition site of gB for the cellular endoprotease furin was destroyed. Because mutagenesis of essential proteins may result in a lethal phenotype, a replication-deficient HCMV gB-null genome encoding enhanced green fluorescent protein was constructed, and complementation by mutant gBs was initially evaluated in transient-cotransfection assays. Cotransfection of plasmids expressing authentic gB or gB with a mutated cleavage site (gB-DeltaFur) led to the formation of green fluorescent miniplaques which were considered to result from one cycle of phenotypic complementation of the gB-null genome. To verify these results, two recombinant HCMV genomes were constructed: HCMV-BAC-DeltaMhdI, with a deletion of hydrophobic domain 1 of gB that appeared to be essential for viral growth in the cotransfection experiments, and HCMV-BACDeltaFur, in which the gB cleavage site was mutated by amino acid substitution. Consistent with the results of the cotransfection assays, only the DeltaFur mutant replicated in human fibroblasts, showing growth kinetics comparable to that of wild-type virus. gB in mutant-infected cells was uncleaved, whereas glycosylation and transport to the cell surface were not impaired. Extracellular mutant virus contained exclusively uncleaved gB, indicating that proteolytic processing of gB is dispensable for viral replication in cell culture.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11773401      PMCID: PMC135784          DOI: 10.1128/jvi.76.3.1252-1264.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Oligomerization of the human cytomegalovirus major envelope glycoprotein complex gB (gp55-116).

Authors:  W J Britt; L G Vugler
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

Review 2.  Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169.

Authors:  M S Chee; A T Bankier; S Beck; R Bohni; C M Brown; R Cerny; T Horsnell; C A Hutchison; T Kouzarides; J A Martignetti
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

3.  Cloning of the human cytomegalovirus (HCMV) genome as an infectious bacterial artificial chromosome in Escherichia coli: a new approach for construction of HCMV mutants.

Authors:  E M Borst; G Hahn; U H Koszinowski; M Messerle
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

4.  Nucleotide sequence and characterization of the Marek's disease virus homologue of glycoprotein B of herpes simplex virus.

Authors:  L J Ross; M Sanderson; S D Scott; M M Binns; T Doel; B Milne
Journal:  J Gen Virol       Date:  1989-07       Impact factor: 3.891

5.  Identification of the gB homologues of equine herpesvirus types 1 and 4 as disulphide-linked heterodimers and their characterization using monoclonal antibodies.

Authors:  D M Meredith; J M Stocks; G R Whittaker; I W Halliburton; B W Snowden; R A Killington
Journal:  J Gen Virol       Date:  1989-05       Impact factor: 3.891

6.  Synthesis and processing of equine herpesvirus type 1 glycoprotein 14.

Authors:  D C Sullivan; G P Allen; D J O'Callaghan
Journal:  Virology       Date:  1989-12       Impact factor: 3.616

7.  Synthesis and processing of the major envelope glycoprotein of murine cytomegalovirus.

Authors:  L C Loh
Journal:  Virology       Date:  1991-01       Impact factor: 3.616

8.  Inhibition of human cytomegalovirus maturation by brefeldin A.

Authors:  M Eggers; E Bogner; B Agricola; H F Kern; K Radsak
Journal:  J Gen Virol       Date:  1992-10       Impact factor: 3.891

9.  An immortalized human fibroblast cell line is permissive for human cytomegalovirus infection.

Authors:  T Compton
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

Review 10.  The molecular biology of influenza virus pathogenicity.

Authors:  H D Klenk; R Rott
Journal:  Adv Virus Res       Date:  1988       Impact factor: 9.937

View more
  22 in total

1.  Cleavage at the furin consensus sequence RAR/KR(109) and presence of the intervening peptide of the respiratory syncytial virus fusion protein are dispensable for virus replication in cell culture.

Authors:  Gert Zimmer; Karl-Klaus Conzelmann; Georg Herrler
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

2.  Cloning of the full-length rhesus cytomegalovirus genome as an infectious and self-excisable bacterial artificial chromosome for analysis of viral pathogenesis.

Authors:  W L William Chang; Peter A Barry
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

3.  Engineering glycoprotein B of bovine herpesvirus 1 to function as transporter for secreted proteins: a new protein expression approach.

Authors:  Günther M Keil; Constanze Höhle; Katrin Giesow; Patricia König
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

4.  Characterization of EBV gB indicates properties of both class I and class II viral fusion proteins.

Authors:  Marija Backovic; George P Leser; Robert A Lamb; Richard Longnecker; Theodore S Jardetzky
Journal:  Virology       Date:  2007-07-25       Impact factor: 3.616

5.  Cleavage of Epstein-Barr virus glycoprotein B is required for full function in cell-cell fusion with both epithelial and B cells.

Authors:  Jessica Sorem; Richard Longnecker
Journal:  J Gen Virol       Date:  2009-03       Impact factor: 3.891

Review 6.  Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme.

Authors:  Judith M White; Sue E Delos; Matthew Brecher; Kathryn Schornberg
Journal:  Crit Rev Biochem Mol Biol       Date:  2008 May-Jun       Impact factor: 8.250

7.  Processing of human cytomegalovirus UL37 mutant glycoproteins in the endoplasmic reticulum lumen prior to mitochondrial importation.

Authors:  Manohara S Mavinakere; Chad D Williamson; Victor S Goldmacher; Anamaris M Colberg-Poley
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

8.  Analysis of Epstein-Barr virus glycoprotein B functional domains via linker insertion mutagenesis.

Authors:  Jessica J Reimer; Marija Backovic; Charuhas G Deshpande; Theodore Jardetzky; Richard Longnecker
Journal:  J Virol       Date:  2008-11-05       Impact factor: 5.103

9.  Nuclear egress and envelopment of herpes simplex virus capsids analyzed with dual-color fluorescence HSV1(17+).

Authors:  Claus-Henning Nagel; Katinka Döhner; Mojgan Fathollahy; Tanja Strive; Eva Maria Borst; Martin Messerle; Beate Sodeik
Journal:  J Virol       Date:  2007-12-26       Impact factor: 5.103

10.  Crimean-Congo hemorrhagic fever virus glycoprotein processing by the endoprotease SKI-1/S1P is critical for virus infectivity.

Authors:  Eric Bergeron; Martin J Vincent; Stuart T Nichol
Journal:  J Virol       Date:  2007-09-26       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.